Covered recipient · General Payments record
BENJAMIN J BARENBERG
Allopathic & Osteopathic Physicians Obstetrics & Gynecology Urogynecology and Reconstructive Pelvic Surgery
General Payments · PY2018–2024
$40,101.20
- Reported across 402 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $598.15 | 30 |
| Education | $79.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Axonics Modulation Technologies, Inc. | $178.90 | 11 |
| Minerva Surgical, Inc | $126.97 | 2 |
| Astellas Pharma US Inc | $119.37 | 3 |
| Organon LLC | $44.04 | 3 |
| Hologic Sales and Service, LLC | $36.98 | 2 |
| Lilly USA, LLC | $35.99 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $29.77 | 1 |
| ABBVIE INC. | $20.02 | 1 |
| Exeltis, USA Inc. | $16.57 | 1 |
| DEXCOM, INC. | $15.46 | 1 |
| Corcept Therapeutics | $14.56 | 1 |
| PFIZER INC. | $13.72 | 1 |
| Meditrina | $13.03 | 1 |
| MAYNE PHARMA COMMERCIAL LLC | $12.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.02 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103279213 | CMS |
| Astellas Pharma US Inc | $22.13 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139324426 | CMS |
| Astellas Pharma US Inc | $17.25 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139326488 | CMS |
| Astellas Pharma US Inc | $79.99 | 10/17/2024 | Education | Undisputed | 01/23/2026 | 1139419617 | CMS |
| Axonics, Inc. | $14.73 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142359323 | CMS |
| Axonics, Inc. | $4.34 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142359339 | CMS |
| Axonics, Inc. | $13.33 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142359341 | CMS |
| Axonics, Inc. | $17.88 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142359353 | CMS |
| Axonics, Inc. | $22.31 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142359357 | CMS |
| Axonics, Inc. | $24.01 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142359359 | CMS |
| Axonics, Inc. | $23.52 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142359389 | CMS |
| Axonics, Inc. | $21.98 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142359375 | CMS |
| Axonics, Inc. | $14.87 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142359405 | CMS |
| Axonics, Inc. | $13.90 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142359411 | CMS |
| Axonics, Inc. | $8.03 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142359417 | CMS |
| Boston Scientific Corporation | $29.77 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092596607 | CMS |
| Corcept Therapeutics | $14.56 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117762089 | CMS |
| Dexcom, Inc. | $15.46 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153285607 | CMS |
| Exeltis, USA Inc. | $16.57 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149985839 | CMS |
| Hologic Sales and Service, LLC | $20.32 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084891023 | CMS |
| Hologic Sales and Service, LLC | $16.66 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084891013 | CMS |
| Lilly USA, LLC | $14.66 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136062190 | CMS |
| Lilly USA, LLC | $21.33 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136066105 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $12.76 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154710103 | CMS |
| Meditrina | $13.03 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154267410 | CMS |
| Minerva Surgical, Inc | $31.72 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1085612747 | CMS |
| Minerva Surgical, Inc | $95.25 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1085612749 | CMS |
| Organon Llc | $17.38 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136213517 | CMS |
| Organon Llc | $11.75 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136213521 | CMS |
| Organon Llc | $14.91 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136213519 | CMS |
| PFIZER INC. | $13.72 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131447015 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.